Endologix PowerLink
This article was originally published in The Gray Sheet
Executive Summary
First two modules of a PMA for less-invasive abdominal aortic aneurysm treatment system are submitted to FDA May 15. Included are manufacturing, quality systems and animal study data. Completion of the PMA, with 12-month follow up on 193 patients, is expected in the third quarter...